Literature DB >> 15625558

Modes of inhibition of cysteine proteases.

Malgorzata Rzychon1, Dorota Chmiel, Justyna Stec-Niemczyk.   

Abstract

Cysteine proteases are involved in many physiological processes and their hyperactivity may lead to severe diseases. Nature has developed various strategies to protect cells and whole organisms against undesired proteolysis. One of them is the control of proteolytic activity by inhibition. This paper presents the mechanisms underlying the action of proteinaceous inhibitors of cysteine proteinases and covers propeptides binding backwards relative to the substrate or distorting the protease catalytic centre similarly to serpins, the p35 protein binding covalently to the enzyme, and cystatins that are exosite binding inhibitors. The paper also discusses tyropins and chagasins that, although unrelated to cystatins, inhibit cysteine proteinases by a similar mechanism, as well as inhibitors of the apoptosis protein family that bind in a direction opposite to that of the substrate, similarly to profragments. Special attention is given to staphostatins, a novel family of inhibitors acting in an unusual manner.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15625558     DOI: 045104861

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  19 in total

1.  Purification and characterization of four new cysteine endopeptidases from fruits of Bromelia pinguin L. grown in Cuba.

Authors:  Juan Abreu Payrol; Walter D Obregón; Sebastián A Trejo; Néstor O Caffini
Journal:  Protein J       Date:  2008-02       Impact factor: 2.371

2.  Activation of cathepsin L by the cathelin-like domain of protegrin-3.

Authors:  Shunyi Zhu; Liang Wei; Kenshi Yamasaki; Richard L Gallo
Journal:  Mol Immunol       Date:  2008-03-04       Impact factor: 4.407

3.  The co-crystal structure of ubiquitin carboxy-terminal hydrolase L1 (UCHL1) with a tripeptide fluoromethyl ketone (Z-VAE(OMe)-FMK).

Authors:  Christopher W Davies; Joseph Chaney; Gregory Korbel; Dagmar Ringe; Gregory A Petsko; Hidde Ploegh; Chittaranjan Das
Journal:  Bioorg Med Chem Lett       Date:  2012-05-04       Impact factor: 2.823

Review 4.  Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes.

Authors:  Reik Löser; Jens Pietzsch
Journal:  Front Chem       Date:  2015-06-23       Impact factor: 5.221

5.  Novel Death Defying Domain in Met entraps the active site of caspase-3 and blocks apoptosis in hepatocytes.

Authors:  Jihong Ma; Chunbin Zou; Lida Guo; Danushka S Seneviratne; Xinping Tan; Yong-Kook Kwon; Jiyan An; Robert Bowser; Marie C DeFrances; Reza Zarnegar
Journal:  Hepatology       Date:  2014-04-01       Impact factor: 17.425

6.  De novo design of 7-aminocoumarin derivatives as novel falcipain-3 inhibitors.

Authors:  Anand S Chintakrindi; Mushtaque S Shaikh; Evans C Coutinho
Journal:  J Mol Model       Date:  2011-07-23       Impact factor: 1.810

7.  Drug Targets: Screening for Small Molecules that Inhibit Fasciola hepatica Enzymes.

Authors:  Florencia Ferraro; Mauricio A Cabrera; Guzmán I Álvarez; Ileana Corvo
Journal:  Methods Mol Biol       Date:  2020

8.  Expression, purification, and characterization of human cystatin C monomers and oligomers.

Authors:  Tyler J Perlenfein; Regina M Murphy
Journal:  Protein Expr Purif       Date:  2015-09-25       Impact factor: 1.650

9.  Apoplastic effectors secreted by two unrelated eukaryotic plant pathogens target the tomato defense protease Rcr3.

Authors:  Jing Song; Joe Win; Miaoying Tian; Sebastian Schornack; Farnusch Kaschani; Muhammad Ilyas; Renier A L van der Hoorn; Sophien Kamoun
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

10.  An extended AE-rich N-terminal trunk in secreted pineapple cystatin enhances inhibition of fruit bromelain and is posttranslationally removed during ripening.

Authors:  Leon W Neuteboom; Kristie O Matsumoto; David A Christopher
Journal:  Plant Physiol       Date:  2009-07-31       Impact factor: 8.340

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.